Intranasal and intraperitoneal immunization against Brucella infection using niosome and mannosylated niosomes containing Brucella recombinant trigger factor/Bp26/Omp31 chimeric protein in a mouse model.
Fahimeh SharifRazieh NazariMahdi Fasihi-RamandiRamezan Ali TaheriMohsen ZargarPublished in: Clinical and experimental vaccine research (2024)
that selectively induces cellular and humoral immune response can be done by selecting a suitable nanoniosome formulation as an immunoadjuvant and recombinant protein as an immune response-stimulating Ag.